Bond Gilead Medica 5.1% ( US375558CC55 ) in USD
| Issuer | Gilead Medica |
| Market price | |
| Country | United States
|
| ISIN code |
US375558CC55 ( in USD )
|
| Interest rate | 5.1% per year ( payment 2 times a year) |
| Maturity | 15/06/2035 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | / |
| Total amount | / |
| Cusip | 375558CC5 |
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) |
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 15/06/2026 ( In 126 days ) |
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Medica ( United States ) , in USD, with the ISIN code US375558CC55, pays a coupon of 5.1% per year. The coupons are paid 2 times per year and the Bond maturity is 15/06/2035 The Bond issued by Gilead Medica ( United States ) , in USD, with the ISIN code US375558CC55, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Medica ( United States ) , in USD, with the ISIN code US375558CC55, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
United States